Weighted Protein Interaction Network Analysis of Frontotemporal Dementia

The genetic analysis of complex disorders has undoubtedly led to the identification of a wealth of associations between genes and specific traits. However, moving from genetics to biochemistry one gene at a time has, to date, rather proved inefficient and under-powered to comprehensively explain the molecular basis of phenotypes. Here we present a novel approach, weighted protein–protein interaction network analysis (W-PPI-NA), to highlight key functional players within relevant biological processes associated with a given trait. This is exemplified in the current study by applying W-PPI-NA to frontotemporal dementia (FTD): We first built the state of the art FTD protein network (FTD-PN) and then analyzed both its topological and functional features. The FTD-PN resulted from the sum of the individual interactomes built around FTD-spectrum genes, leading to a total of 4198 nodes. Twenty nine of 4198 nodes, called inter-interactome hubs (IIHs), represented those interactors able to bridge over 60% of the individual interactomes. Functional annotation analysis not only reiterated and reinforced previous findings from single genes and gene-coexpression analyses but also indicated a number of novel potential disease related mechanisms, including DNA damage response, gene expression regulation, and cell waste disposal and potential biomarkers or therapeutic targets including EP300. These processes and targets likely represent the functional core impacted in FTD, reflecting the underlying genetic architecture contributing to disease. The approach presented in this study can be applied to other complex traits for which risk-causative genes are known as it provides a promising tool for setting the foundations for collating genomics and wet laboratory data in a bidirectional manner. This is and will be critical to accelerate molecular target prioritization and drug discovery.

[1]  John Hardy,et al.  Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences , 2016, Briefings Bioinform..

[2]  A. Ciechanover,et al.  The ubiquitin-proteasome system and autophagy: Coordinated and independent activities. , 2016, The international journal of biochemistry & cell biology.

[3]  Albert-László Barabási,et al.  Endophenotype Network Models: Common Core of Complex Diseases , 2016, Scientific Reports.

[4]  T. Golde,et al.  Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies , 2016, Journal of neurochemistry.

[5]  Brian T. Naughton,et al.  Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases , 2016, Nature Biotechnology.

[6]  S. Gunawardena,et al.  Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics , 2016, Marine drugs.

[7]  R. Purohit,et al.  Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight , 2016, Cell Biochemistry and Biophysics.

[8]  L. Wan,et al.  Deficit of RACK1 contributes to the spatial memory impairment via upregulating BECLIN1 to induce autophagy. , 2016, Life sciences.

[9]  Robert H. Brown,et al.  CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia , 2016, Nature Communications.

[10]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[11]  Human genetics: Loss-of-function variants — not always what they seem , 2016, Nature Reviews Genetics.

[12]  R. Rademakers,et al.  Genetics of FTLD: overview and what else we can expect from genetic studies , 2016, Journal of neurochemistry.

[13]  Minghua Nie,et al.  Cooperativity of the SUMO and Ubiquitin Pathways in Genome Stability , 2016, Biomolecules.

[14]  Jason D. Warren,et al.  Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis , 2016, Molecular Neurodegeneration.

[15]  Ruth McPherson,et al.  Genetics of Coronary Artery Disease. , 2016, Circulation research.

[16]  R. Jahn,et al.  Functions of Rab Proteins at Presynaptic Sites , 2016, Cells.

[17]  Michael F. Green,et al.  Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study , 2016, Schizophrenia Research.

[18]  A. Mahadevan,et al.  Tripartite containing motif 32 modulates proliferation of human neural precursor cells in HIV-1 neurodegeneration , 2015, Cell Death and Differentiation.

[19]  S. Jo,et al.  Overexpression of Cell Cycle Proteins of Peripheral Lymphocytes in Patients with Alzheimer's Disease , 2015, Psychiatry investigation.

[20]  E. Citterio Fine-tuning the ubiquitin code at DNA double-strand breaks: deubiquitinating enzymes at work , 2015, Front. Genet..

[21]  Daniel H. Geschwind,et al.  Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders , 2015, Nature Reviews Genetics.

[22]  J. Frade,et al.  Neuronal cell cycle: the neuron itself and its circumstances , 2015, Cell cycle.

[23]  Lili Wang,et al.  PINBPA: Cytoscape app for network analysis of GWAS data , 2015, Bioinform..

[24]  Shao Li,et al.  Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[25]  M. Mira,et al.  Genetics of leprosy: expected and unexpected developments and perspectives. , 2015, Clinics in dermatology.

[26]  M. Ritchie Finding the epistasis needles in the genome-wide haystack. , 2015, Methods in molecular biology.

[27]  Magda Tsolaki,et al.  Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology , 2014, Alzheimer's & Dementia.

[28]  A. Singleton,et al.  Genetic variability in the regulation of gene expression in ten regions of the human brain , 2014, Nature Neuroscience.

[29]  Li Wang,et al.  Histone Acetyltransferase p300 Mediates Histone Acetylation of PS1 and BACE1 in a Cellular Model of Alzheimer's Disease , 2014, PloS one.

[30]  G. Abecasis,et al.  Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.

[31]  Alexander Gerhard,et al.  Frontotemporal dementia and its subtypes: a genome-wide association study , 2014, The Lancet Neurology.

[32]  E. Génin,et al.  A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. , 2014, Brain : a journal of neurology.

[33]  Hans Förstl,et al.  Frontotemporal lobar degeneration: current perspectives , 2014, Neuropsychiatric disease and treatment.

[34]  Carlos Cruchaga,et al.  TMEM106B: a strong FTLD disease modifier , 2014, Acta Neuropathologica.

[35]  M. Daly,et al.  Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.

[36]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[37]  Rafael C. Jimenez,et al.  The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..

[38]  J. Mill,et al.  Analysis of HSPA8 and HSPA9 mRNA expression and promoter methylation in the brain and blood of Alzheimer's disease patients. , 2013, Journal of Alzheimer's disease : JAD.

[39]  S. Sleiman,et al.  Epigenetics of Alzheimer’s Disease and Frontotemporal Dementia , 2013, Neurotherapeutics.

[40]  Dmitriy Minond,et al.  COPS5 (Jab1) Protein Increases β Site Processing of Amyloid Precursor Protein and Amyloid β Peptide Generation by Stabilizing RanBP9 Protein Levels* , 2013, The Journal of Biological Chemistry.

[41]  Amber L. Couzens,et al.  The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.

[42]  Michael Krawczak,et al.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease , 2013, Human Genetics.

[43]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[44]  P. Momeni,et al.  Molecular Genetics of Frontotemporal Dementia , 2013 .

[45]  H. Rosen,et al.  Neuroimaging in frontotemporal dementia , 2013, International review of psychiatry.

[46]  M. Sabbagh,et al.  Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations , 2013, Neurochemistry International.

[47]  Karin Breuer,et al.  InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation , 2012, Nucleic Acids Res..

[48]  N. Cairns,et al.  Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects , 2012, Acta Neuropathologica.

[49]  Sandra Orchard,et al.  Molecular interaction databases , 2012, Proteomics.

[50]  T. Arendt Cell Cycle Activation and Aneuploid Neurons in Alzheimer's Disease , 2012, Molecular Neurobiology.

[51]  Henning Hermjakob,et al.  Analyzing protein-protein interaction networks. , 2012, Journal of proteome research.

[52]  E. Lander,et al.  The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.

[53]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[54]  J. Rohrer,et al.  Phenotypic signatures of genetic frontotemporal dementia. , 2011, Current opinion in neurology.

[55]  G. Ammerer,et al.  Controlling gene expression in response to stress , 2011, Nature Reviews Genetics.

[56]  Jaak Vilo,et al.  g:Profiler—a web server for functional interpretation of gene lists (2011 update) , 2011, Nucleic Acids Res..

[57]  D. Butterfield,et al.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ , 2011, Neuroscience.

[58]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[59]  Jason H. Moore,et al.  Missing heritability and strategies for finding the underlying causes of complex disease , 2010, Nature Reviews Genetics.

[60]  L. Stein,et al.  A human functional protein interaction network and its application to cancer data analysis , 2010, Genome Biology.

[61]  M. J. Fresnadillo Martínez,et al.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.

[62]  G. Rabinovici,et al.  Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management , 2010 .

[63]  M. Barcikowska,et al.  PIN1 gene variants in Alzheimer's disease , 2009, BMC Medical Genetics.

[64]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[65]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[66]  V. Haroutunian,et al.  nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing. , 2009, Journal of Alzheimer's disease : JAD.

[67]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[68]  A. Passaro,et al.  Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia , 2008, Journal of the Neurological Sciences.

[69]  M. Khoury,et al.  The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? , 2007, Genetics in Medicine.

[70]  A. Barzilai The contribution of the DNA damage response to neuronal viability. , 2006, Antioxidants & redox signaling.

[71]  K. Fliessbach,et al.  Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.

[72]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[73]  Joël Zlotogora,et al.  Penetrance and expressivity in the molecular age , 2003, Genetics in Medicine.

[74]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[75]  M. Tyers,et al.  The GRID: The General Repository for Interaction Datasets , 2003, Genome Biology.

[76]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[77]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[78]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.